RA Capital Management’s Entera Bio ENTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTX
SFCM
SL
KCM
RA Capital Management's ENTX Position: Q3 2026 in Review
RA Capital Management opened a new position in Entera Bio (ENTX) in Q3 2026: 4,901,960 shares worth $14.3M. The stake represents 0.14% of the portfolio and ranks #68 among its holdings. This is a return to the name: RA Capital Management previously reported a position in ENTX as recently as Q1 2023.
RA Capital Management first reported a position in ENTX in Q2 2021 and has held it in 9 quarters since. 46 funds tracked by Wall St. Rank hold ENTX as of Q3 2026.
- RA Capital Management held 4,901,960 shares of Entera Bio worth $14.3M as of Q3 2026.
- Entera Bio was a new RA Capital Management position in Q3 2026.
- Entera Bio made up 0.14% of RA Capital Management's portfolio in Q3 2026, its #68 holding.
- RA Capital Management first reported a position in Entera Bio in Q2 2021 and has held it in 9 quarters since.
- 46 funds tracked by Wall St. Rank held Entera Bio as of Q3 2026.
Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.